Weight loss drug for reducing liver pressure in cirrhosis
Treatments studied
Part of Digestive system clinical trials.
This study tests a weight loss medication (mazdutide) in people with cirrhosis and high blood pressure in the liver. It may help reduce liver pressure and prevent complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have cirrhosis caused by hepatitis B or C, fatty liver disease, or alcohol.
- Your liver pressure is high (measured by a test called HVPG).
- You are overweight or obese (BMI of 28 or higher, or 26 with related health issues).
- Your weight has been stable for the past 6 months (no change of more than 3 kg).
- You have not had serious liver complications like bleeding or fluid in the belly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if metformin can lower the pressure in the liver's blood vessels (portal hypertension) in people with cirrhosis. The goal is to see if it can help reduce complications like swelling or bleeding.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
This study tests whether mazdutide, a medicine that may help with weight and blood sugar, can reduce plaque buildup in the heart's arteries. It is for people who are overweight or obese and have some narrowing in their heart arteries but do not need immediate procedures like stents.
This trial tests if a medicine called Mazdutide can help overweight living liver donors who have a fatty liver condition (MASLD) lose weight and improve their liver health before donating part of their liver. It aims to make the donation safer and more successful.
This trial tests whether mazdutide, a new medicine, can improve blood sugar and reduce liver fat in people with type 2 diabetes and moderate-to-severe fatty liver who are already taking semaglutide (a weekly injection). It aims to find a more effective treatment for these combined conditions.
This study tests a medication called mazdutide, which is given after sleeve gastrectomy (a weight-loss surgery) to help with further weight loss and improve health. The medication is taken as a supplement to the surgery and may help you lose more weight than surgery alone.
Hear when a new Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.